Source comparison
CJC-1295 Dosage Comparison: DAC vs Non-DAC
CJC-1295 without DAC (Mod GRF 1-29) 200–300mcg per dose 2–3× per week (Mon/Wed/Fri or Mon/Thu) ~30 minutes Pulsatile. Matches natural 90–120 min GH rhythm Low. Short receptor occupancy preserves sensitivity Best for long-term anti-aging protocols; mimics physi
This comparison does not assign a generated winner or score.
- CJC-1295 without DAC (Mod GRF 1-29)
- 200–300mcg per dose
- 2–3× per week (Mon/Wed/Fri or Mon/Thu)
- ~30 minutes
- Pulsatile. Matches natural 90–120 min GH rhythm
- Low. Short receptor occupancy preserves sensitivity
- Best for long-term anti-aging protocols; mimics physiological pulsatility and maintains receptor responsiveness across 16–24 week cycles
- CJC-1295 with DAC
- 500–1000mcg per dose
- Once weekly
- 6–8 days
- Tonic. Sustained low-level receptor activation
- Moderate to High. Extended receptor occupancy may reduce responsiveness after 8–12 weeks
- Convenient for compliance but may require cycling (8 weeks on, 4 weeks off) to prevent diminishing IGF-1 response
- Combination Protocol (CJC + GHRP-2)
- 200mcg CJC + 100mcg GHRP-2 per dose
- 2–3× per week
- CJC ~30 min, GHRP ~30 min
- Synergistic pulsatile. Increased amplitude and frequency
- Moderate. Dual-pathway activation requires monitoring for insulin resistance markers
- Produces 4–5× baseline GH output; reserved for tissue repair research, not standard longevity protocols due to metabolic load